Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial.
Masataka YagisawaHiroya TaniguchiTaroh SatohShigenori KadowakiYu SunakawaTomohiro NishinaYoshito KomatsuTaito EsakiDaisuke SakaiAyako DoiTakeshi KajiwaraHiromi OnoMasatoshi AsanoNami HiranoJustin OdegaardSatoshi FujiiShogo NomuraHideaki BandoAkihiro SatoTakayuki YoshinoYoshiaki NakamuraPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
-amplified solid tumors determined with cfDNA testing.